EASY BIO,Inc. (KOSDAQ:353810)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,570.00
-10.00 (-0.15%)
Jun 10, 2026, 3:30 PM KST

EASY BIO,Inc. Revenue

EASY BIO,Inc. had revenue of 130.69B KRW in the quarter ending March 31, 2026, with 11.77% growth. This brings the company's revenue in the last twelve months to 490.70B, up 11.05% year-over-year. In the year 2025, EASY BIO,Inc. had annual revenue of 476.94B with 24.10% growth.

Revenue (ttm)
490.70B
Revenue Growth
+11.05%
P/S Ratio
0.44
Revenue / Employee
3.72B
Employees
132
Market Cap
217.68B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025476.94B92.61B24.10%
Dec 31, 2024384.33B218.95B132.39%
Dec 31, 2023165.39B9.83B6.32%
Dec 31, 2022155.56B26.10B20.16%
Dec 31, 2021129.46B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Bioneer338.01B
Macrogen199.60B
BINEX164.00B
GC Cell163.35B
JETEMA,77.07B
HLB Therapeutics67.56B
Anterogen.Co.,Ltd.8.06B
Genexine5.81B
Revenue Rankings